This review summarizes the clinical significance of BCR structure and function in CLL, which has provided insight into novel therapeutics and fostered the design of (immuno)chemotherapy-free treatment algorithms. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.